Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cues.
about
Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cues.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-coreceptor therapy drives ...... on-dependent chemotactic cues.
@en
Anti-coreceptor therapy drives ...... on-dependent chemotactic cues.
@nl
type
label
Anti-coreceptor therapy drives ...... on-dependent chemotactic cues.
@en
Anti-coreceptor therapy drives ...... on-dependent chemotactic cues.
@nl
prefLabel
Anti-coreceptor therapy drives ...... on-dependent chemotactic cues.
@en
Anti-coreceptor therapy drives ...... on-dependent chemotactic cues.
@nl
P2093
P2860
P1433
P1476
Anti-coreceptor therapy drives ...... on-dependent chemotactic cues.
@en
P2093
Aaron J Martin
Douglas E Kline
Fatima Manzoor
Gregory Gojanovich
Keith Miller
Matthew Clark
Roland Tisch
Y Maurice Morillon
P2860
P304
P356
10.1172/JCI.INSIGHT.87636
P577
2016-10-20T00:00:00Z